<DOC>
	<DOC>NCT01014494</DOC>
	<brief_summary>This study is being undertaken to verify the safety and performance of Adaprevâ„¢, a Class III medical device, when administered as a short term implant into the tendon sheath at the time of surgery, on the post-operative function of severed digital tendons. Subjects are randomised to either Adaprev or standard care and attend visits for 26 weeks following surgery. This clinical investigation will recruit 44 subjects in the UK at up to 10 clinical trial sites.</brief_summary>
	<brief_title>Adaprev in Digital Flexor Tendon Repair</brief_title>
	<detailed_description />
	<mesh_term>Tendon Injuries</mesh_term>
	<criteria>Subjects aged 18 years and above with complete division of the Flexor Digitorum Profundus (FDP) tendon in Zone II. Subjects with additional complicated injuries Subjects whose flexor tendon repair involves a finger with less than full tendon function prior to the injury requiring repair Subjects who are undergoing surgical repair of the severed tendon(s) more than four days after the injury occurred. Subjects with a history of clinical significant hypersensitivity to any of the devices, drugs or surgical dressings to be used in this trial. Subjects with conditions which may delay healing. Subjects who are taking, or have taken, any investigational drugs within 3 months prior to the screening visit. Females who are pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
</DOC>